17.05.2016 • NewsElaine BurridgeAlbemarleChemetall

Albemarle Mulls Sale of Chemetall

US specialty chemicals company Albemarle is exploring the sale of its Chemetall surface-treatment division, according to the news agency Bloomberg. People familiar with the matter told the news agency CEO Luke Kissam is looking for ways to help pay down debt from its $6.2 billion acquisition of Rockwood Holdings in 2014.

Bank of America reportedly has been hired to advise on strategic options for Chemetall, which provides surface-treatment chemicals for metals and plastics and is believed to be worth as much as $3 billion.

Albemarle sold two other businesses earlier this year – minerals and metal sulphides – but abandoned the sale of a a third operation supplying fine chemicals as it did not receive high enough bids.

Chemetall, which was part of the Rockwood deal, reported EBITDA of $52.5 million in the first quarter of 2016, up 14% year on year.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.